Volgen
Kim Pelak
Kim Pelak
Geverifieerd e-mailadres voor duke.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
J He, O Abdel-Wahab, MK Nahas, K Wang, RK Rampal, AM Intlekofer, ...
Blood, The Journal of the American Society of Hematology 127 (24), 3004-3014, 2016
2742016
The characterization of twenty sequenced human genomes
K Pelak, KV Shianna, D Ge, JM Maia, M Zhu, JP Smith, ET Cirulli, J Fellay, ...
PLoS genetics 6 (9), e1001111, 2010
1972010
Copy number variation of KIR genes influences HIV-1 control
K Pelak, AC Need, J Fellay, KV Shianna, S Feng, TJ Urban, D Ge, ...
PLoS biology 9 (11), e1001208, 2011
1822011
Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis
D Oz-Levi, B Ben-Zeev, EK Ruzzo, Y Hitomi, A Gelman, K Pelak, ...
The American Journal of Human Genetics 91 (6), 1065-1072, 2012
1772012
Host determinants of HIV-1 control in African Americans
K Pelak, DB Goldstein, NM Walley, J Fellay, D Ge, KV Shianna, C Gumbs, ...
The Journal of infectious diseases 201 (8), 1141-1149, 2010
1762010
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy
EK Ruzzo, JM Capo-Chichi, B Ben-Zeev, D Chitayat, H Mao, AL Pappas, ...
Neuron 80 (2), 429-441, 2013
1752013
Using ERDS to infer copy-number variants in high-coverage genomes
M Zhu, AC Need, Y Han, D Ge, JM Maia, Q Zhu, EL Heinzen, ET Cirulli, ...
The American Journal of Human Genetics 91 (3), 408-421, 2012
1592012
A genomic score prognostic of outcome in trauma patients
HS Warren, CM Elson, DL Hayden, DA Schoenfeld, JP Cobb, RV Maier, ...
Molecular medicine 15, 220-227, 2009
1072009
CCL3L1 and HIV/AIDS susceptibility
TJ Urban, AC Weintrob, J Fellay, S Colombo, KV Shianna, C Gumbs, ...
Nature medicine 15 (10), 1110-1112, 2009
922009
SVA: software for annotating and visualizing sequenced human genomes
D Ge, EK Ruzzo, KV Shianna, M He, K Pelak, EL Heinzen, AC Need, ...
Bioinformatics 27 (14), 1998-2000, 2011
842011
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans
PJ McLaren, S Ripke, K Pelak, AC Weintrob, NA Patsopoulos, X Jia, ...
Human molecular genetics 21 (19), 4334-4347, 2012
712012
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A
J Lane, PJ McLaren, L Dorrell, KV Shianna, A Stemke, K Pelak, S Moore, ...
Human molecular genetics 22 (9), 1903-1910, 2013
482013
A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting
CL Nelson, K Pelak, MV Podgoreanu, SH Ahn, WK Scott, AS Allen, ...
BMC infectious diseases 14, 1-8, 2014
432014
Clinical utility of coronary CT angiography: coronary stenosis detection and prognosis in ambulatory patients
JR Lesser, B Flygenring, T Knickelbine, H Hara, J Henry, A Kalil, K Pelak, ...
Catheterization and Cardiovascular Interventions 69 (1), 64-72, 2007
372007
National Institute of Allergy and Infectious Diseases Center for HIV
K Pelak, DB Goldstein, NM Walley, J Fellay, D Ge, KV Shianna, C Gumbs, ...
AIDS Vaccine Immunology (CHAVI). Host determinants of HIV-1 control in …, 2010
332010
International HIV Controllers Study. Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans
PJ McLaren, S Ripke, K Pelak, AC Weintrob, NA Patsopoulos, X Jia, ...
Hum Mol Genet 21 (19), 4334-4347, 2012
132012
Comprehensive analysis of tumor NGS data to demonstrate pathways pointing to therapeutic targeting options.
S Krishnan, A Perlina, A Thomas, B Kakaradov, W Delport, RB Nehring, ...
Journal of Clinical Oncology 35 (15_suppl), e23153-e23153, 2017
2017
Tumor profiling from whole-genome and whole transcriptome sequencing to uncover gene fusions and structural variations in clinically relevant cancer genes.
AE Gylfe, E Shinbrot, B Kakaradov, W Delport, CK Lau, S Krishnan, ...
Journal of Clinical Oncology 35 (15_suppl), e23118-e23118, 2017
2017
Abstract A208: Mutation detection in FFPE and plasma circulating DNA with a focused ALK-EGFR-KRAS Next-Generation Sequencing panel.
P Fang, A Darwanto, Z Yan, W Liu, K Pelak, J Kristof, PC Mack, S Sankar, ...
Molecular Cancer Therapeutics 12 (11_Supplement), A208-A208, 2013
2013
Complementary analysis of LKB1/STK11 mutation and protein expression status using next-generation sequencing, Sanger sequencing and immunohistochemistry.
K Pelak, J Wright, Z Yan, A Darwanto, W Liu, P Fang, J Li, S Sankar, ...
Cancer Research 73 (8_Supplement), 3509-3509, 2013
2013
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20